Rick Wise
Stock Analyst at Stifel
(4.36)
# 280
Out of 4,827 analysts
237
Total ratings
62.18%
Success rate
10.8%
Average return
Main Sectors:
Stocks Rated by Rick Wise
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ZBH Zimmer Biomet Holdings | Maintains: Buy | $138 → $115 | $95.75 | +20.10% | 15 | May 6, 2025 | |
| BDX Becton, Dickinson and Company | Maintains: Buy | $280 → $224 | $169.99 | +31.77% | 8 | May 2, 2025 | |
| CNMD CONMED | Downgrades: Hold | $75 → $55 | $58.28 | -5.62% | 11 | Apr 28, 2025 | |
| ABT Abbott Laboratories | Maintains: Buy | $135 → $145 | $135.16 | +7.28% | 20 | Apr 17, 2025 | |
| KMTS Kestra Medical Technologies | Initiates: Buy | $28 | $22.41 | +24.94% | 1 | Mar 31, 2025 | |
| KIDS OrthoPediatrics | Maintains: Buy | $40 → $32 | $22.85 | +40.04% | 6 | Mar 5, 2025 | |
| LIVN LivaNova | Maintains: Buy | $72 → $60 | $44.43 | +35.04% | 6 | Feb 26, 2025 | |
| AORT Artivion | Maintains: Buy | $33 → $30 | $28.98 | +3.52% | 6 | Feb 25, 2025 | |
| ATRC AtriCure | Maintains: Buy | $36 → $48 | $31.62 | +51.80% | 13 | Feb 13, 2025 | |
| BSX Boston Scientific | Maintains: Buy | $115 → $120 | $105.03 | +14.25% | 17 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $75 → $90 | $76.10 | +18.27% | 23 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $400 → $440 | $387.46 | +13.56% | 16 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $170 → $155 | $156.43 | -0.91% | 6 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $525 → $610 | $544.25 | +12.08% | 17 | Dec 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $170 → $190 | $158.50 | +19.87% | 14 | Nov 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $38 | $32.05 | +18.56% | 8 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $7 → $8 | $7.58 | +5.54% | 8 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $16 | $3.76 | +325.53% | 4 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $82 | $67.73 | +21.07% | 1 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $100 → $102 | $71.22 | +43.22% | 2 | Sep 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $85 → $87 | $84.56 | +2.89% | 11 | Aug 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $9 → $12 | $4.99 | +140.72% | 3 | Jul 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $59 → $75 | $82.57 | -9.17% | 1 | Apr 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $17 → $24 | $23.12 | +3.83% | 7 | Feb 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $390 → $90 | $16.00 | +462.50% | 4 | Oct 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | $25 | $12.73 | +96.39% | 4 | Jun 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $103 → $112 | $51.88 | +115.88% | 5 | Oct 2, 2020 |
Zimmer Biomet Holdings
May 6, 2025
Maintains: Buy
Price Target: $138 → $115
Current: $95.75
Upside: +20.10%
Becton, Dickinson and Company
May 2, 2025
Maintains: Buy
Price Target: $280 → $224
Current: $169.99
Upside: +31.77%
CONMED
Apr 28, 2025
Downgrades: Hold
Price Target: $75 → $55
Current: $58.28
Upside: -5.62%
Abbott Laboratories
Apr 17, 2025
Maintains: Buy
Price Target: $135 → $145
Current: $135.16
Upside: +7.28%
Kestra Medical Technologies
Mar 31, 2025
Initiates: Buy
Price Target: $28
Current: $22.41
Upside: +24.94%
OrthoPediatrics
Mar 5, 2025
Maintains: Buy
Price Target: $40 → $32
Current: $22.85
Upside: +40.04%
LivaNova
Feb 26, 2025
Maintains: Buy
Price Target: $72 → $60
Current: $44.43
Upside: +35.04%
Artivion
Feb 25, 2025
Maintains: Buy
Price Target: $33 → $30
Current: $28.98
Upside: +3.52%
AtriCure
Feb 13, 2025
Maintains: Buy
Price Target: $36 → $48
Current: $31.62
Upside: +51.80%
Boston Scientific
Feb 10, 2025
Maintains: Buy
Price Target: $115 → $120
Current: $105.03
Upside: +14.25%
Jan 30, 2025
Upgrades: Buy
Price Target: $75 → $90
Current: $76.10
Upside: +18.27%
Jan 29, 2025
Maintains: Buy
Price Target: $400 → $440
Current: $387.46
Upside: +13.56%
Jan 23, 2025
Maintains: Hold
Price Target: $170 → $155
Current: $156.43
Upside: -0.91%
Dec 5, 2024
Maintains: Buy
Price Target: $525 → $610
Current: $544.25
Upside: +12.08%
Nov 22, 2024
Reiterates: Buy
Price Target: $170 → $190
Current: $158.50
Upside: +19.87%
Nov 11, 2024
Maintains: Buy
Price Target: $46 → $38
Current: $32.05
Upside: +18.56%
Nov 6, 2024
Maintains: Hold
Price Target: $7 → $8
Current: $7.58
Upside: +5.54%
Oct 31, 2024
Maintains: Buy
Price Target: $17 → $16
Current: $3.76
Upside: +325.53%
Oct 8, 2024
Initiates: Buy
Price Target: $82
Current: $67.73
Upside: +21.07%
Sep 30, 2024
Maintains: Buy
Price Target: $100 → $102
Current: $71.22
Upside: +43.22%
Aug 21, 2024
Maintains: Hold
Price Target: $85 → $87
Current: $84.56
Upside: +2.89%
Jul 16, 2024
Upgrades: Buy
Price Target: $9 → $12
Current: $4.99
Upside: +140.72%
Apr 26, 2024
Upgrades: Buy
Price Target: $59 → $75
Current: $82.57
Upside: -9.17%
Feb 5, 2024
Maintains: Hold
Price Target: $17 → $24
Current: $23.12
Upside: +3.83%
Oct 13, 2023
Maintains: Buy
Price Target: $390 → $90
Current: $16.00
Upside: +462.50%
Jun 21, 2023
Reiterates: Hold
Price Target: $25
Current: $12.73
Upside: +96.39%
Oct 2, 2020
Maintains: Hold
Price Target: $103 → $112
Current: $51.88
Upside: +115.88%